Johnson & Johnson

Stories 1 - 20 |  Next >>

Lung Cancer Patients Benefit From 'Golden Age' of Research
On Lung Cancer Front,
an 'Amazing' Development
NEW STUDY
Oct 8, 2024 3:14 PM CDT

On Lung Cancer Front, an 'Amazing' Development

Drug combination found to bring longer control to patients with EGFR mutation

(Newser) - Lung cancer kills 1.8 million people every year, making it the leading cause of cancer death worldwide. With advances in precision medicine, however, doctors are helping prevent even more deaths, including with a drug combination just approved by the FDA in August. The results of a phase 3 trial...

Will 3rd Time Be the Charm for Johnson & Johnson?

Proposed settlement to resolve ovarian cancer lawsuits a lot like its first two plans

(Newser) - Johnson & Johnson has a new plan to resolve tens of thousands of lawsuits alleging that asbestos in its talc-based products, including baby powder, cause ovarian cancer—and it has a lot in common with the company's previous two plans. Johnson & Johnson has proposed a settlement of almost...

Washington Announces $150M Opioid Settlement With Drugmaker

It's about $20M more than state would have received under national settlement

(Newser) - More than four years after suing Johnson & Johnson over the drugmaker's role in the opioid crisis, Washington state has reached a $149.5 million settlement with the company. The deal, which must still be approved by a judge, would send $123.3 million to state and local governments...

Johnson & Johnson Changing Logo After 136 Years

Company is ditching the cursive script for a noncursive approach

(Newser) - Johnson & Johnson is signing off on a new logo. The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices, per the AP . The original script—based...

Johnson & Johnson Offers $8.9B to Settle Talc Lawsuits

If approved, settlement would cover all current and future claims

(Newser) - Johnson & Johnson is earmarking nearly $9 billion to cover allegations that its baby power containing talc caused cancer, more than quadrupling the amount that the company had previously set aside to pay for its potential liability, the AP reports. Under a proposal announced Tuesday, a J&J subsidiary will...

Johnson & Johnson's 'No-Brainer' Fix on Baby Powder

Cornstarch will take its place, starting next year, after complaints talc caused cancer

(Newser) - You already won't find Johnson & Johnson baby powder containing talc on most store shelves in the US and Canada, but now the company is nixing the ingredient in that product worldwide, after tens of thousands of complaints were filed alleging it caused cancer in consumers who used it....

FDA Limits Authorized Use of Johnson & Johnson Vaccine

If they can, adults should get Moderna or Pfizer coronavirus shots, agency says

(Newser) - Referring to new data on blood clots, the Food and Drug Administration announced limits Thursday on who should and should not be administered Johnson & Johnson's coronavirus vaccine. Only adults unable to receive other vaccines instead, either because the products are inaccessible or they're not clinically appropriate, are...

J&J Is Pausing COVID Vaccine Production

Move is said to be temporary, but some are raising concerns

(Newser) - The only Johnson & Johnson plant that had been making usable batches of the company's COVID-19 vaccine is no longer producing it, a move that could reduce the global supply of the vaccine by a few hundred million doses, sources tell the New York Times . J&J quietly made...

CDC Panel Backs Other Vaccines Over J&J's
CDC:
Get Pfizer or
Moderna,
Not J&J
UPDATED
Dec 17, 2021 2:51 AM CST

CDC: Get Pfizer or Moderna, Not J&J

CDC makes official new recommendation

(Newser) - Update: The CDC is now officially taking the stance that that "mRNA vaccines are preferred over [Johnson & Johnson's] Janssen COVID-19 vaccine for the prevention of COVID-19 for those 18 years of age and over." Within hours of a panel making that recommendation, the CDC director accepted...

Supreme Court Delivers Blow to J&J Over Baby Powder

Justices let suit brought by Mississippi over health risks proceed

(Newser) - The Supreme Court on Monday turned away a request by Johnson & Johnson to halt a Mississippi lawsuit over its talcum powder products, per the AP . As is typical, the high court didn't say anything in turning away the case, which was included in a long list of cases...

2 More Conglomerates Are Breaking Up

J&J, Toshiba announce plans to separate their businesses in coming years

(Newser) - Johnson & Johnson plans to split into two publicly traded companies. And in case you're wondering, no, they won't be called "Johnson I" and "Johnson II." Johnson & Johnson will keep its name and its title as the world's largest health-products company by sales...

Court Overturns $465M Opioid Ruling Against Johnson & Johnson

It's the second blow to a case like this in the past month

(Newser) - The Oklahoma Supreme Court on Tuesday overturned a $465 million opioid ruling against drugmaker Johnson & Johnson, finding that a lower court wrongly interpreted the state's public nuisance law in the first case of its kind in the US to go to trial. The ruling was the second blow...

Booster Shots Are Expected to Start Going in Arms Today

CDC, Walensky gave final approval Thursday night

(Newser) - Update: An advisory panel unanimously recommended to the Centers for Disease Control and Prevention on Thursday that coronavirus vaccine booster shots be approved. Tens of millions of people would be eligible for the doses, which the FDA backed the day before, the Washington Post reports. (There's an explainer on...

S&P 500 Closes in on Record High
First Bitcoin ETF
Jumps 4.8% in Market Debut
MARKETS
Oct 19, 2021 3:54 PM CDT

First Bitcoin ETF Jumps 4.8% in Market Debut

S&P 500 is closing in on record high

(Newser) - Stocks closed higher on Wall Street Tuesday, giving the S&P 500 its fifth straight gain and getting it closer to the record high it set in early September. The Dow Jones Industrial Average and the Nasdaq also closed higher. Health care companies made some of the biggest gains. Johnson...

J&J Could've Been 2 Shots All Along, Fauci Says

Booster recipients probably will be able to mix brands

(Newser) - In hindsight, the Johnson & Johnson coronavirus vaccine probably should have been two shots from the start, as other vaccines are, Dr. Anthony Fauci said Sunday. Asked on ABC's This Week whether people who received the company's single dose should be alarmed because an FDA advisory panel has...

FDA Panel Endorses J&J Booster Shot
FDA Panel Endorses
J&J Booster Shot
Oct 15, 2021 1:42 PM CDT

FDA Panel Endorses J&J Booster Shot

Advisers set no timeline but says shot should come at least 2 months after the first one

(Newser) - A panel of US health advisers endorsed booster doses of Johnson & Johnson's single-shot COVID-19 vaccine Friday, saying they should be offered at least two months after immunization. J&J has asked the Food and Drug Administration for flexibility with its booster, the AP reports, arguing that the extra...

FDA Report Is Inconclusive on Johnson & Johnson Booster

Outside advisers are meeting this week to consider approval and interval

(Newser) - It's not clear yet whether people who received the one-shot Johnson & Johnson coronavirus vaccine will be cleared to get a booster shot or will be told to switch brands. A Food and Drug Administration staff report released Wednesday said that there's evidence the J&J booster strengthened...

J&J: Our Booster Shot Works
J&J: Shot No. 2 Works
Sep 21, 2021 6:58 AM CDT

J&J: Shot No. 2 Works

Company's data has not been peer-reviewed, but this is a first step

(Newser) - Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose, per the AP . J&J said in statement Tuesday that it ran two early studies in people previously given its vaccine and found...

J&J Shuts Down HIV Vaccine Trial
J&J Shuts Down 
HIV Vaccine Trial
Aug 31, 2021 2:39 PM CDT

J&J Shuts Down HIV Vaccine Trial

Study in five African countries found that it only provided 25% protection

(Newser) - Scientists searching for an HIV vaccine have been disappointed yet again. Johnson & Johnson says it has shut down a vaccine trial in Africa that started in 2017 after finding that it only provided 25% protection, the New York Times reports. The trial involved young women at high risk of...

Johnson & Johnson: Booster Pumps Up Antibodies Big Time

Company says booster at least 6 months later caused bigger spike in antibodies than first shot

(Newser) - The Pfizer vaccine now known as Comirnaty has received full approval from the Food and Drug Administration, paving the way for booster shots. Moderna's full OK from the FDA is said to be just a few weeks away, and now Johnson & Johnson announced Wednesday that people who received...

Stories 1 - 20 |  Next >>